StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Neurocrine Biosciences, Inc.
NasdaqGS:NBIX
Sector
Location
Market Cap
USD 13.08 B
Share Price
USD 132.14
Avg Daily Volume
1,322,248
Change (1 day)
0.38%
Change (1 year)
-9.55%
Change (YTD)
-3.19%
Neurocrine Biosciences, Inc. Share Price Year-To-Date (YTD) return on July 25, 2025: -3.19%
Neurocrine Biosciences, Inc. Share Price Year-To-Date (YTD) return is -3.19% on July 25, 2025. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance. Year-to-Date (YTD) return is is the percentage change in the price of a stock from the start of the calendar year up to the current date, it shows how much the stock has gained or lost since the beginning of the year.
-
Neurocrine Biosciences, Inc. 52-week low Share Price is USD 153.29 on July 25, 2025, which is 16.01% above the current Share Price.
-
Neurocrine Biosciences, Inc. 52-week low Share Price is USD 87.54 on July 25, 2025, which is -33.75% below the current Share Price.
-
Neurocrine Biosciences, Inc. average Share Price for the last 52 weeks is USD 124.63.
Competitors
Eli Lilly and Company
USD 812.69
LLY
+7.26
0.90%
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
GSK plc
USD 18.71
GSK.L
-0.07
-0.36%
Regeneron Pharmaceuticals, Inc.
USD 563.10
REGN
-1.54
-0.27%
MERCK Kommanditgesellschaft auf Aktien
USD 132.20
MRK.DE
-0.95
-0.72%
Cencora, Inc.
USD 290.36
COR
-0.09
-0.03%
Key Data
| Date | Share Price Year-To-Date (YTD) return | Price to Earnings Ratio (P/E) | Price to Book Ratio (P/B) | Price to Sales Ratio (P/S) |
|---|
Competitors
Eli Lilly and Company
USD 812.69
LLY
+7.26
0.90%
AbbVie Inc.
USD 190.28
ABBV
-0.55
-0.29%
Novo Nordisk A/S
USD 70.93
NOVO-B.CO
+0.75
1.07%
Roche Holding AG
USD 345.06
RO.SW
-6.70
-1.91%
Novartis AG
USD 116.76
NOVN.SW
-0.57
-0.49%
AstraZeneca PLC
USD 145.14
AZN.L
-2.14
-1.46%
Abbott Laboratories
USD 126.54
ABT
+0.90
0.72%
Merck & Co., Inc.
USD 84.71
MRK
+0.60
0.71%
Amgen Inc.
USD 306.58
AMGN
-1.97
-0.64%
Pfizer Inc.
USD 24.79
PFE
-0.56
-2.21%
Gilead Sciences, Inc.
USD 116.20
GILD
+3.00
2.65%
Sanofi
USD 99.93
SAN.PA
-0.18
-0.18%
Vertex Pharmaceuticals Incorporated
USD 469.65
VRTX
-2.62
-0.56%
Bristol-Myers Squibb Company
USD 48.43
BMY
-0.51
-1.04%
CSL Limited
USD 175.87
CSL.AX
-1.75
-0.98%
Chugai Pharmaceutical Co., Ltd.
USD 49.71
4519.T
+0.51
1.03%
GSK plc
USD 18.71
GSK.L
-0.07
-0.36%
Regeneron Pharmaceuticals, Inc.
USD 563.10
REGN
-1.54
-0.27%
MERCK Kommanditgesellschaft auf Aktien
USD 132.20
MRK.DE
-0.95
-0.72%
Cencora, Inc.
USD 290.36
COR
-0.09
-0.03%